Frankfurt
03.07.25 | 09:15
0,457 Euro
-0,98 % -0,005
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,461 | 0,504 | 09:36 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Senzime Secures Major U.S. Hospital Contract for Supply and Scientific Collaboration | 156 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced it has secured a contract to supply TetraGraph monitors and enter a scientific collaboration with... ► Artikel lesen | |
| SENZIME Aktie jetzt für 0€ handeln | |||||
| Di | Senzime Granted New U.S. Patent for TetraGraph System | 131 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent protecting and... ► Artikel lesen | |
| Mo | BULLETIN from EXTRAORDINARY GENERAL MEETING in Senzime AB | 147 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / June 30, 2025 / The extraordinary general meeting in Senzime AB (STO:SEZI)(OTCQX:SNZZF), corp. reg. no 556565-5734 (the "Company") was held on 30 June 2025, whereby... ► Artikel lesen | |
| Mo | New Number of Shares and Votes in Senzime AB | 170 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 30, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime AB (publ) ("Senzime") has increased during June due to the directed share... ► Artikel lesen | |
| 02.06. | NOTICE OF extraordinary GENERAL MEETING in Senzime AB | 278 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / June 2, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby to an extraordinary general... ► Artikel lesen | |
| 26.05. | Senzime Applauds Announcement of Upcoming European Pediatric Guidelines of Neuromuscular Monitoring | 259 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Lisbon, Portugal - Senzime AB (publ.) welcomes today's pre-announcement of the first pediatric guidelines of quantitative... ► Artikel lesen | |
| 19.05. | BULLETIN from Annual General Meeting in Senzime AB | 267 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2025 at... ► Artikel lesen | |
| 29.04. | Senzime Secures New TetraGraph Contract with State-Wide University Hospital System in Southern US | 238 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime AB today announced that it has secured another major US contract, this time with a top-ranked... ► Artikel lesen | |
| 24.04. | Senzime Publishes Annual and Sustainability Report for 2024 | 243 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / April 24, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) announces today that the company's annual and sustainability report for 2024 is published and available at the website... ► Artikel lesen | |
| 23.04. | Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System | 198 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an additional system-wide contract with a US healthcare system. The contract includes... ► Artikel lesen | |
| 22.04. | Senzime: Interim Report January-March 2025: 94 Percent Growth | 207 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 22, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2025 is now available on the company's website www.senzime.comFinancial... ► Artikel lesen | |
| 14.04. | Invitation to Presentation of Senzime's First Quarter 2025 Report | 190 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22... ► Artikel lesen | |
| 14.04. | NOTICE OF ANNUAL GENERAL MEETING in Senzime AB | 251 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general... ► Artikel lesen | |
| 03.04. | Senzime Comments on US Market Tariffs | 278 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 2025."We... ► Artikel lesen | |
| 01.04. | New Number of Shares and Votes in Senzime AB | 176 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / April 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime has increased during the month of March due to the directed issue of shares... ► Artikel lesen | |
| 14.03. | Senzime Secures Additional US Hospital System Contracts | 319 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 14, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next-generation... ► Artikel lesen | |
| 17.02. | Senzime: Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate | 186 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESS Newswire / February 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.senzime.com.Financial... ► Artikel lesen | |
| 13.02. | Invitation to Presentation of Senzime's Fourth Quarter 2024 Report | 232 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on... ► Artikel lesen | |
| 13.01. | Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway | 485 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a second... ► Artikel lesen | |
| 07.01. | Senzime Secures Multiple New Hospital Contracts for its Next-Generation TetraGraph System | 555 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins... ► Artikel lesen |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROCEPT BIOROBOTICS | 58,18 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CAPSOVISION | 3,500 | 0,00 % | CapsoVision Prices IPO Of 5.50 Mln Shares At $5.00/shr | WASHINGTON (dpa-AFX) - CapsoVision Inc. (CV), a commercial-stage medical technology company that develops
advanced imaging and artificial intelligence technologies that are deployed in its... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 22,010 | 0,00 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
| ALIGNMENT HEALTHCARE | 13,610 | -4,22 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,710 | -1,26 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| MIMEDX | 6,230 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2025 Operating and Financial Results | Net Sales of $88 million Grew 4% Year-Over-Year for the First Quarter First Quarter GAAP Net Income and Earnings Per Share were $7 Million and $0.05, Respectively First Quarter Adjusted EBITDA... ► Artikel lesen | |
| FRESENIUS | 42,300 | +0,05 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Fresenius auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt... ► Artikel lesen | |
| PHETON | 18,380 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
| NUTEX HEALTH | 122,29 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| GENEDX | 89,79 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
| SIEMENS HEALTHINEERS | 47,370 | -0,11 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 2,440 | 0,00 % | The Oncology Institute wird exklusiver Anbieter für Nevada Medicaid | ||
| 908 DEVICES | 6,605 | 0,00 % | 908 Devices Inc.: Romanian Customs Authority Adopts 908 Devices' MX908 for Border Security Operations | The handheld mass spectrometers are now in active use for trace detection and identification of drugs and explosives for customs and border patrol applications 908 Devices Inc. (Nasdaq: MASS)... ► Artikel lesen | |
| GOODRX | 5,055 | +1,92 % | GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies | ||
| PROGYNY | 21,240 | -3,72 % | Progyny, Inc.: Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women's health and family building, today announced the appointments of Melissa Cummings as the company's first... ► Artikel lesen |
SENZIME AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,005 (-0,98 %) liegt der Kurs bei 0,457 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SENZIME AB finden Sie auf Wallstreet Online.